Regina Brown - 11 May 2011 Form 3 Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Role
Director
Signature
/s/ Regina Brown
Issuer symbol
LIXT
Transactions as of
11 May 2011
Net transactions value
$0
Form type
3
Filing time
14 May 2021, 06:10:15 UTC
Next filing
02 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LIXT Common Stock 1,300 11 May 2011 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LIXT Options to Purchase Common Stock 11 May 2011 Common Stock 250,000 $2.80 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

The Reporting Person was granted five-year options to purchase an aggregate of 250,000 shares of the Company's Common Stock vesting 125,000 shares as of May 11,2021 and the remainder vesting on the last day of each subsequent calendar quarter-end until fully vested.